Global Regenerative Medicines Market – Future Growth Trend and Analysis

• Analysis
• 20-July-2016

The Regenerative Medicines Market Research report offered by Decisiondatabases.com covers the growth trend and complete market overview. The report is useful for business strategists for gaining a detailed understanding about the market, its value chain, competitor study and detailed company profiles.
 

Regenerative medicines are advanced pills to refurbish the lost functionality of organs or tissues. It is an emerging field of medicine, which aims to replace, regenerate or repair damaged organs and tissues in the living human body by stimulating severely damaged organs into healing on their own. Rising prevalence of bone-related diseases, advancements in stem cell & nanotechnology application, shortage of organ donors and high rejection rate of transplants are major market drivers foreseen to boost regenerative medicines market demand under the study period. In addition, increasing healthcare spending along with rising geriatric population will further fuel the demand in the near future. However, availability of alternative technologies and high expense of the treatment are the major challenges for the market, which may affect the market growth.

Increasing financial funding and rising contract manufacturing vendors will have a positive impact on the growth of global regenerative medicine market. These medicines are expected to treat incurable chronic disorders and conditions such as Alzheimer's disease, diabetes, Parkinson's disease, heart disease, osteoporosis, renal failure and spinal cord injuries. Regenerative medicines are a multidisciplinary field, which bring together physics, chemistry, and biology and applied engineering and merge the therapeutic property of biological entities with the accuracy and steadiness of engineered biomaterials.

The global regenerative medicines market is segmented based on technology into stem cell therapy, gene therapy, phases of clinical trials, tissue engineering, and small molecules and biologics. Gene therapy is one of the fastest growing segments and is expected to grow at a significant rate over the forecast period owing to the growing demand for organ transplantation due to its ability to reduce the immune reactions after post transplantation. Furthermore, the regenerative medicines market is segmented based on the products and applications.

Studying the geographical coverage of the market, North America and Europe together, accounted for major market share and are projected to grow at a lucrative rate over the coming years on account of the rising technological innovation and increasing R&D expenditure for the development of technology in the region. Asia Pacific is anticipated to witness a substantial growth over the forecast period owing to the high disposable income and expanding healthcare industry in the region.

The major industry players include Aastrom Biosciences, Inc., Advanced Cell Technology, Athersys, Inc., Amgen Inc., Bioheart, Inc., Cytori Therapeutics Inc., Celgene Corporation, Geron Corporation, Genzyme Corporation, Osiris Therapeutics, Inc., Japan Tissue Engineering Co.,  Ltd., ThermoGenesis Corp. are the key players of global regenerative medicine market.
In July 2016, Kyocera Corporation, RIKEN, and Organ Technologies have jointly launched a research in to develop a Regenerative Medicine to treat alopecia (Hair Loss)
 
In March 2016, the official introduction of the Manchester Regenerative Medicine (MaRM) Network happened at the Whitworth Art Gallery.
In March 2016, Avita Medical has launched two regenerative medicines, ReGenerCell to cure chronic wounds and ReNovaCell for re-pigmentation issue.

Other Related Reports
 
About-Us:
 
DecisionDatabases.com is a global business research reports provider, enriching decision makers and strategists with qualitative statistics. DecisionDatabases.com is proficient in providing syndicated research report, customized research reports, company profiles and industry databases across multiple domains.
 
Our expert research analysts have been trained to map client’s research requirements to the correct research resource leading to a distinctive edge over its competitors. We provide intellectual, precise and meaningful data at a lightning speed.
 
For more details:
DecisionDatabases.com
E-Mail:  [email protected]
Phone: +91 99 28 237112
Web: www.decisiondatabases.com/